Antibiotic Resistance

  • 05.09.2018  |  Unleashing biotech’s crouching tiger

    NATURE BIOTECHNOLOGY | With a massive expansion in healthcare coverage, biotech's next big boom could occur in India. The country has launched the world's largest publicly funded healthcare scheme. Termed 'Modicare’ which could drive investment into the biotech and pharma sector.

    Full Story

  • 04.15.2018  |  Analysis reveals mechanisms behind pan-resistant pathogen

    CIDRAP | Scientists have identified the resistance strains in the carbapenem-resistant Enterobacteriaceae (CRE) bacteria responsible for the death of a Nevada woman in 2016. She died of septic shock. The CRE bacteria - K pneumoniae - was resistant to 26 different antibiotics and is an example of the type of 'nightmare' bacteria the CDC has detected in hospitals in more than 30 states.

    Full Story

  • 04.03.2018  |  ‘Nightmare bacteria’ widespread in U.S. hospitals

    SCIENTIFIC AMERICAN | The Centers for Disease Control and Prevention detected more than 220 cases last year of a rare breed of “nightmare bacteria” that are virtually untreatable and capable of spreading genes that make them impervious to most antibiotics, according to a report released Tuesday.

    Full Story

  • 03.26.2018  |  Global antibiotic use rises, fueled by economic growth

    CIDRAP | Overall global antibiotic use climbed by 65% from 2000 through 2015. A large new study of antibiotic use in humans shows an alarming rise in consumption around the world, driven predominantly by rising living standards in low- and middle-income countries (LMICs).

    Full Story

  • 03.22.2018  |  Price to pay: Antibiotic-resistant infections cost $2 billion a year

    CIDRAP | US study says cases of drug resistance are on the rise, almost doubling from 2002 to 2014, adding extra costs to health care on top of costing lives.

    Full Story